NANOBIOTIX
LIVE

Serial Number

79292951

Owner

Nanobiotix

Attorney

James R Menker

Filing Date

Jun 30, 2020

Add to watchlist:

No watchlists yet
View on USPTO

NANOBIOTIX Trademark

Serial Number: 79292951 • Registration: 6382972

NANOBIOTIX is a trademark filed by Nanobiotix on June 30, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Nanobiotix

60 rue de Wattignies
Paris 75012 , FR

Entity Type: 03

Trademark Details

Filing Date

June 30, 2020

Registration Date

June 15, 2021

Published for Opposition

March 30, 2021

Goods & Services

Scientific and technological services, namely, research and design services particularly in the field of nanomedicine which is nanotechnology applied to medicine; biological research; research in bacteriology; scientific research, namely, evaluations, estimates and research in scientific and technological fields provided by engineers, researchers; design and development of new products for third parties; technical project studies, namely, technical research in the field of nanomedicine; industrial analysis of manufacturing of nanomedicines and research services in the field of nanomedicine; chemical analysis; chemical research; chemistry services, namely, chemistry consultation; surveying

Surgical and medical apparatus and instruments, namely radiotherapy apparatus especially for the diagnosis and treatment of tumors using radiotherapy; radiotherapy apparatus; testing apparatus for medical use, namely, for testing tumor characteristics; diagnostic apparatus for medical use, namely, for testing tumor characteristics; radiological apparatus for medical use; apparatus and installations for the production of X-Rays for medical use

Healthcare especially in the field of nanomedicine; medical services especially in the field of nanomedicine; hospital services; medical assistance; physiotherapy

Pharmaceutical products, namely, preparations for medical use particularly for tumor diagnosis and treatment; pharmaceutical products, namely, preparations for medical use, especially for the diagnosis and treatment of tumors using radiotherapy; radioactive products, namely, substances for medical use, especially for the diagnosis and treatment of tumors using radiotherapy; health products, namely, pharmaceutical products, for the treatment of tumors; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of tumors; diagnostic products for medical use, namely, medicines for the treatment of tumors; drugs for medical use, namely, pharmaceutical products for use in the treatment of cancer; medicines for human medicine, namely, pharmaceutical products for the treatment of tumors; chemico-pharmaceutical products for use in treating oncological diseases and disorders; pharmaceutical products for use in treating oncological diseases and disorders

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 15, 2026 REM3
CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Jun 3, 2022 CORN
CORRECTION TRANSACTION RECEIVED FROM IB
Apr 23, 2022 CRCV
FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 30, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 1, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 1, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 15, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 15, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 30, 2021 NPUB
PUBLISHED FOR OPPOSITION
Mar 30, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Mar 28, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 10, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 10, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 10, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 24, 2021 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 24, 2021 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 24, 2021 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 24, 2021 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 24, 2021 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 15, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 15, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 15, 2021 TROA
REFUSAL PROCESSED BY IB
Nov 2, 2020 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 13, 2020 RFCS
REFUSAL PROCESSED BY MPU
Oct 13, 2020 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 9, 2020 RFCR
NON-FINAL ACTION WRITTEN
Oct 8, 2020 CNRT
ASSIGNED TO EXAMINER
Oct 6, 2020 DOCK
APPLICATION FILING RECEIPT MAILED
Sep 8, 2020 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 4, 2020 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Sep 3, 2020 REPR